[HTML][HTML] Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial …

GRA Ferrari, ES Becker, F Smit, M Rinck, J Spijker - BMC psychiatry, 2016 - Springer
Background Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

[PDF][PDF] Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial …

GRA Ferrari, ES Becker, F Smit, M Rinck, J Spijker - 2016 - core.ac.uk
Background: Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol

GRA Ferrari, ES Becker, F Smit, M Rinck… - BMC …, 2016 - search.proquest.com
Background Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): A randomized controlled trial protocol.

GRA Ferrari, ES Becker, F Smit, M Rinck… - BMC …, 2016 - psycnet.apa.org
Background: Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

[PDF][PDF] Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial …

GRA Ferrari, ES Becker, F Smit, M Rinck, J Spijker - 2016 - researchgate.net
Background: Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.

GRA Ferrari, ES Becker, F Smit, M Rinck… - BMC …, 2016 - search.ebscohost.com
Background: Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

[HTML][HTML] Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial …

GRA Ferrari, ES Becker, F Smit… - BMC …, 2016 - bmcpsychiatry.biomedcentral.com
Despite the range of available, evidence-based treatment options for Major Depressive
Disorder (MDD), the rather low response and remission rates suggest that treatment is not …

Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.

GR Ferrari, ES Becker, F Smit, M Rinck, J Spijker - BMC Psychiatry, 2016 - europepmc.org
Background Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol

GRA Ferrari, ES Becker, F Smit, M Rinck, J Spijker - 2016 - pubmed.ncbi.nlm.nih.gov
Background Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …

[HTML][HTML] Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial …

GRA Ferrari, ES Becker, F Smit, M Rinck… - BMC …, 2016 - ncbi.nlm.nih.gov
Background Despite the range of available, evidence-based treatment options for Major
Depressive Disorder (MDD), the rather low response and remission rates suggest that …